CAR-T is an acronym for chimeric antigen receptor T-cell. The idea is that the body's naturally occurring <a href="https://quoteddata.com/glossary/t-cell/">T-cells</a> are reprogrammed to attack cancer. The T-cells can be harvested from the patient or another donor. If the therapy is working correctly, only the cancer cells are targeted and healthy cells are unaffected.